Chemours (CC) PT Lowered to $62 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Chemours (CC) PT Lowered to $68 at BMO Capital
August 6, 2018 8:30 AM EDTBMO Capital lowered its price target on Chemours (NYSE: CC) to $68.00 (from $70.00) while maintaining a Outperform rating.
... MoreChemours (CC) PT Lowered to $47 at UBS
August 3, 2018 8:48 AM EDTUBS lowered its price target on Chemours (NYSE: CC) to $47.00 (from $50.00) while maintaining a Neutral rating.
... MoreChemours (CC) Tops Q2 EPS by 12c
August 2, 2018 4:38 PM EDTChemours (NYSE: CC) reported Q2 EPS of $1.71, $0.12 better than the analyst estimate of $1.59. Revenue for the quarter came in at $1.8 billion versus the consensus estimate of $1.82 billion.
For earnings history and earnings-related data on Chemours (CC) click here.
... More